demonstrated that FAM3C inhibited the proliferation and invasion of esophageal cancer under miR‐574‐3p‐mediated regulation, suggesting its potential as a therapeutic target in esophageal cancer treatment [7]. The gene discussed is FAM3C; the disease is esophageal cancer.